無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の髄膜炎診断検査市場:ラテックス凝集検査、ラテラルフローアッセイ、PCRアッセイ、ELISA、培養検査 - 産業分析、市場規模、シェア、成長、動向、予測2017年〜2025年

Meningitis Diagnostic Testing Market (Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

発行 Transparency Market Research 商品コード 621281
出版日 ページ情報 英文 162 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.91円で換算しております。
Back to Top
世界の髄膜炎診断検査市場:ラテックス凝集検査、ラテラルフローアッセイ、PCRアッセイ、ELISA、培養検査 - 産業分析、市場規模、シェア、成長、動向、予測2017年〜2025年 Meningitis Diagnostic Testing Market (Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
出版日: 2018年03月07日 ページ情報: 英文 162 Pages
概要

当レポートでは、世界の髄膜炎診断検査市場を調査し、市場の概要、製品・エンドユーザー・地域別の市場動向、市場規模の推移と予測、市場シェア、成長促進・阻害要因および市場機会の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲と市場セグメンテーション
  • 調査のハイライト

第2章 前提条件と調査方法

  • 前提条件
  • 頭字語
  • 調査方法

第3章 エグゼクティブサマリー

第4章 市場の概要

  • 製品の概要
  • 主要産業イベント
  • 市場規模の推移と予測
  • 市場機会マップ
  • ファイブフォース分析
  • 市場見通し

第5章 市場のダイナミクス

  • 成長要因・促進要因の概要
  • 成長要因
  • 阻害要因
  • 市場動向
  • 主要企業の成長要因
  • インビトロ診断(IVD)市場:合併・買収
  • 規制シナリオ

第6章 世界の髄膜炎診断検査市場の分析:製品別

  • イントロダクション
  • 主な所見
  • 市場シェア:製品別
  • 市場予測:製品別
    • ラテックス凝集検査(LAT)
    • ラテラルフローアッセイ
    • PCRアッセイ
    • ELISA
    • 培養検査
    • その他
  • 市場魅力分析:製品別

第7章 世界の髄膜炎診断検査市場の分析:エンドユーザー別

  • イントロダクション
  • 主な所見
  • 市場シェア:エンドユーザー別
  • 市場予測:エンドユーザー別
    • 病院
    • 診断センター
    • その他
  • 市場魅力分析:エンドユーザー別

第8章 世界の髄膜炎診断検査市場の分析:地域別

  • 市場シナリオ
  • 市場シェア:地域別
  • 市場予測:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析:地域別

第9章 北米

第10章 欧州

第11章 アジア太平洋

第12章 ラテンアメリカ

第13章 中東・アフリカ

第14章 競合情勢

  • 企業シェアの分析
  • 競合分析
  • 会社概要
    • Fast Track Diagnostics Ltd. (FTD) - Siemens Healthineers
    • Thermo Fisher Scientific, Inc.
    • Abbott Laboratories.
    • Bio-Rad Laboratories, Inc.
    • Seegene Inc.
    • DiagCor Bioscience Inc. Ltd
    • BioFire Diagnostics (bioMerieux)
    • IMMY
    • Nanosphere (Luminex Corporation).
図表

List of Tables

  • TABLE 1 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by Product, 2015-2025
  • TABLE 2 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 3 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast, by Region, 2015-2025
  • TABLE 4 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 5 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015-2025
  • TABLE 6 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 7 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country /Sub-region, 2015-2025
  • TABLE 8 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015-2025
  • TABLE 9 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 10 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • TABLE 11 Table 11: Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015-2025
  • TABLE 12 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 13 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • TABLE 14 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015-2025
  • TABLE 15 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 16 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • TABLE 17 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015-2025
  • TABLE 18 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 19 Fast Track Diagnostics Ltd. (FTD) - Siemens Healthineers Business Overview
  • TABLE 20 Thermo Fisher Scientific, Inc. Business Overview
  • TABLE 21 Abbott Laboratories Business Overview
  • TABLE 22 Bio-Rad Laboratories, Inc. Business Overview
  • TABLE 23 Seegene Inc. Business Overview
  • TABLE 24 DiagCor Bioscience Inc. Ltd Business Overview
  • TABLE 25 BioFire Diagnostics (bioMerieux) Business Overview
  • TABLE 26 IMMY Business Overview
  • TABLE 27 Nanosphere (Luminex Corporation) Business Overview

List of Figures

  • FIG. 1 Global Meningitis Diagnostics Testing Market Share (US$ Mn), by Product, 2016
  • FIG. 2 Global Meningitis Diagnostics Testing Market Share (%), by End User, 2016
  • FIG. 3 Revenue Share, by product, 2016
  • FIG. 4 Revenue Share, by end user, 2016
  • FIG. 5 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2025
  • FIG. 6 Market Value Share, by Product (2016)
  • FIG. 7 Market Value Share, by Distribution Channel (2016)
  • FIG. 8 Market Value Share, by Region (2016)
  • FIG. 9 Global Meningitis Diagnostic Testing Market Value Share, by Product, 2016 and 2025
  • FIG. 10 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Latex Agglutination Test, 2015-2025
  • FIG. 11 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Lateral Flow Assay, 2015-2025
  • FIG. 12 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PCR Assay, 2015-2025
  • FIG. 13 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by ELISA Test, 2015-2025
  • FIG. 14 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Culture Test, 2015-2025
  • FIG. 15 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015-2025
  • FIG. 16 Global Meningitis Diagnostic Testing Market Attractiveness, by Product
  • FIG. 17 Global Meningitis Diagnostic Testing Market Value Share, by End-user, 2016 and 2025
  • FIG. 18 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015-2025
  • FIG. 19 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Centers, 2015-2025
  • FIG. 20 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other, 2015-2025
  • FIG. 21 Global Meningitis Diagnostic Testing Market Attractiveness, by End-user
  • FIG. 22 Global Meningitis Diagnostic Testing Market Value Share, by Region, 2016 and 2025
  • FIG. 23 Global Meningitis Diagnostic Testing Attractiveness Analysis, by Region, 2017-2025
  • FIG. 24 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • FIG. 25 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 26 North America Meningitis Diagnostic Testing Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 27 North America Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
  • FIG. 28 North America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 29 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017-2025
  • FIG. 30 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017-2025
  • FIG. 31 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • FIG. 32 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017-2025
  • FIG. 33 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • FIG. 34 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
  • FIG. 35 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 36 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017-2025
  • FIG. 37 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017-2025
  • FIG. 38 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • FIG. 39 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017-2025
  • FIG. 40 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • FIG. 41 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
  • FIG. 42 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 43 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017-2025
  • FIG. 44 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017-2025
  • FIG. 45 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • FIG. 46 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017-2025
  • FIG. 47 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • FIG. 48 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
  • FIG. 49 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 50 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017-2025
  • FIG. 51 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017-2025
  • FIG. 52 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • FIG. 53 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017-2025
  • FIG. 54 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • FIG. 55 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
  • FIG. 56 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 57 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017-2025
  • FIG. 58 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017-2025
  • FIG. 59 Thermo Fisher Scientific, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2016
  • FIG. 60 Thermo Fisher Scientific, Inc. Research & Development Expenses (US$ Mn), 2015-2016
  • FIG. 61 Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2016
  • FIG. 62 Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segment, 2016
  • FIG. 63 Abbott Laboratories Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • FIG. 64 Abbott Laboratories Research & Development Expenses (US$ Bn), 2015-2016
  • FIG. 65 Abbott Laboratories Breakdown of Net Sales, by Region, 2016
  • FIG. 66 Abbott Laboratories Breakdown of Net Sales, by Segment, 2016
  • FIG. 67 Bio-Rad Laboratories, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
  • FIG. 68 Bio-Rad Laboratories, Inc. Research & Development Expenses (US$ Mn), 2015-2016
  • FIG. 69 Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Geography, 2016
  • FIG. 70 Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Segment, 2016
  • FIG. 71 Seegene Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2016
  • FIG. 72 Seegene Inc. Research & Development Expenses (US$ Mn), 2014-2016
  • FIG. 73 Seegene Inc. Breakdown of Net Sales, by Region, 2016
  • FIG. 74 Seegene Inc. Breakdown of Net Sales, by Business Segment, 2016
  • FIG. 75 Nanosphere Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
  • FIG. 76 Nanosphere Research & Development Expenses (US$ Mn), 2014-2016
  • FIG. 77 Nanosphere Breakdown of Net Sales, by Business Segment, 2016
目次

Title:
Meningitis Diagnostic Testing Market (Products - Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test; Industry - Hospitals, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025.

Meningitis Diagnostic Testing Market: Overview

This report on meningitis diagnostic testing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing diagnostic test for meningitis as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global meningitis diagnostic testing market with respect to the leading market segments based on product type, end-user and geographies.

Meningitis Diagnostic Testing Market: Segmentations

The global meningitis diagnostic testing market is divided into three segments: by product, by end user and by geography. Based on the product, the market has been further segmented into six major sub segments latex agglutination tests, lateral flow assay, PCR assay, ELISA tests, culture test, and others. The market has been further studied from the point of view of end user. Based on end user, the market has been segmented into hospitals, diagnostics centers and others

Each of the market segments have been extensively analyzed based on the market related factors such as increase incidence of meningitis and available testing options. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the meningitis diagnostic testing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global meningitis diagnostic testing market.

Geographically, meningitis diagnostic testing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, porter's five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global meningitis diagnostic testing market.

Meningitis Diagnostic Testing Market: Competitive Landscape

Major players operating in the global meningitis diagnostic testing market are Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd. (FTD) - Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Nanosphere (Luminex Corporation), Seegene Inc., Qnostics, ELITechGroup, and Abbott Laboratories exhibit the largest geographical outreach with presence in multiple meningitis diagnostic testing products

The global meningitis diagnostic testing market is segmented as follows:

Global Meningitis Diagnostic Testing Market Revenue, by Product

  • Latex Agglutination Tests
  • Lateral Flow Assay
  • PCR Assay
  • ELISA Tests
  • Culture Test
  • Others

Global Meningitis Diagnostic Testing Market Revenue, by End User

  • Hospital
  • Diagnostic Centers
  • Others

Global Meningitis Diagnostic Testing Market Revenue, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • Middle East & North Africa
    • Sub-Saharan Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Acronyms Used
  • 2.3. Research Methodology

3. Executive Summary

  • 3.1. Global Meningitis Diagnostic Testing Market Snapshot

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Key Industry Events
  • 4.3. Global Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, 2015-2025
  • 4.4. Market Opportunity Map
  • 4.5. Porter's Analysis
  • 4.6. Global Meningitis Diagnostic Testing Market Outlook

5. Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
  • 5.3. Restraints
  • 5.4. Trends
  • 5.1. Key Success factor for Top Players
  • 5.2. Key Mergers and Acquisitions-In vitro Diagnostics (IVD) Industry
  • 5.3. Regulatory Scenario

6. Global Meningitis Diagnostic Testing Market Analysis, by Product

  • 6.1. Introduction
  • 6.2. Key Findings
  • 6.3. Global Meningitis Diagnostic Testing Market Value Share, by Product
  • 6.4. Global Meningitis Diagnostic Testing Market Forecast, by Product
    • 6.4.1. Latex Agglutination Tests
    • 6.4.2. Lateral Flow Assay
    • 6.4.3. PCR Assay
    • 6.4.4. ELISA Tests
    • 6.4.5. Culture Test
    • 6.4.6. Others
  • 6.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product

7. Global Meningitis Diagnostics Testing Market Analysis, by End User

  • 7.1. Introduction
  • 7.2. Key Findings
  • 7.3. Global Meningitis Diagnostic Testing Market Value Share Analysis, by End User
  • 7.4. Global Meningitis Diagnostic Testing Market Forecast, by End User
    • 7.4.1. Hospital
    • 7.4.2. Diagnostic Center
    • 7.4.3. Others
  • 7.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by End User

8. Global Meningitis Diagnostic Testing Market Analysis, by Region

  • 8.1. Global Market Scenario by Country
  • 8.2. Global Meningitis Diagnostic Testing Market Value Share Analysis, by Region
  • 8.3. Global Meningitis Diagnostic Testing Forecast, by Region
    • 8.3.1. North America
    • 8.3.2. Europe
    • 8.3.3. Asia Pacific
    • 8.3.4. Latin America
    • 8.3.5. Middle East & Africa
  • 8.4. Global Meningitis Diagnostic Testing Attractiveness Analysis By Region

9. North America Meningitis Diagnostic Testing Market Analysis

  • 9.1. Key Findings
  • 9.2. Market Overview
  • 9.3. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
  • 9.4. North America Meningitis Diagnostic Testing Market Forecast, by Country
  • 9.5. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
  • 9.6. North America Meningitis Diagnostic Testing Market Forecast, by Product
    • 9.6.1. Latex Agglutination Tests
    • 9.6.2. Lateral Flow Assay
    • 9.6.3. PCR Assay
    • 9.6.4. ELISA Tests
    • 9.6.5. Culture Test
    • 9.6.6. Others
  • 9.7. North America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
  • 9.8. North America Meningitis Diagnostic Testing Market Forecast, by End-user
    • 9.8.1. Hospital
    • 9.8.2. Diagnostic Center
    • 9.8.3. Others
  • 9.9. North America Meningitis Diagnostic Testing Market Attractiveness Analysis

10. Europe Meningitis Diagnostic Testing Market Analysis

  • 10.1. Key Findings
  • 10.2. Market Overview
  • 10.3. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Country
  • 10.4. Europe Meningitis Diagnostic Testing Market Forecast, by Country
    • 10.4.1. U.S.
    • 10.4.2. Canada
  • 10.5. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Product
  • 10.6. Europe Meningitis Diagnostic Testing Market Forecast, by Product
    • 10.6.1. Latex Agglutination Tests
    • 10.6.2. Lateral Flow Assay
    • 10.6.3. PCR Assay
    • 10.6.4. ELISA Tests
    • 10.6.5. Culture Test
    • 10.6.6. Others
  • 10.7. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
  • 10.8. Europe Meningitis Diagnostic Testing Market Forecast, by End-user
    • 10.8.1. Hospital
    • 10.8.2. Diagnostic Center
    • 10.8.3. Others
  • 10.9. Europe Meningitis Diagnostic Testing Market Attractiveness Analysis

11. Asia Pacific Meningitis Diagnostic Testing Market Analysis

  • 11.1. Key Findings
  • 11.2. Market Overview
  • 11.3. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Country
  • 11.4. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Country
    • 11.4.1. U.K.
    • 11.4.2. Germany
    • 11.4.3. France
    • 11.4.4. Italy
    • 11.4.5. Spain
    • 11.4.6. Rest of Europe
  • 11.5. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Product
  • 11.6. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Product
    • 11.6.1. Latex Agglutination Tests
    • 11.6.2. Lateral Flow Assay
    • 11.6.3. PCR Assay
    • 11.6.4. ELISA Tests
    • 11.6.5. Culture Test
    • 11.6.6. Others
  • 11.7. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
  • 11.8. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by End-user
    • 11.8.1. Hospital
    • 11.8.2. Diagnostic Center
    • 11.8.3. Others
  • 11.9. Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis

12. Latin America Meningitis Diagnostic Testing Market Analysis

  • 12.1. Key Findings
  • 12.2. Market Overview
  • 12.3. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
    • 12.3.1. Brazil
    • 12.3.2. Mexico
    • 12.3.3. Rest of Latin America
  • 12.4. Latin America Meningitis Diagnostic Testing Market Forecast, by Country
  • 12.5. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
  • 12.6. Latin America Meningitis Diagnostic Testing Market Forecast, by Product
    • 12.6.1. Latex Agglutination Tests
    • 12.6.2. Lateral Flow Assay
    • 12.6.3. PCR Assay
    • 12.6.4. ELISA Tests
    • 12.6.5. Culture Test
    • 12.6.6. Others
  • 12.7. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
  • 12.8. Latin America Meningitis Diagnostic Testing Market Forecast, by End-user
    • 12.8.1. Hospital
    • 12.8.2. Diagnostic Center
    • 12.8.3. Others
  • 12.9. Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis

13. Middle East & Africa Meningitis Diagnostic Testing Market Analysis

  • 13.1. Key Findings
  • 13.2. Market Overview
  • 13.3. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Country
    • 13.3.1. Middle East & North Africa
    • 13.3.2. Sub-Saharan Africa
    • 13.3.3. Rest of Africa
  • 13.4. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Country
  • 13.5. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Product
  • 13.6. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Product
    • 13.6.1. Latex Agglutination Tests
    • 13.6.2. Lateral Flow Assay
    • 13.6.3. PCR Assay
    • 13.6.4. ELISA Tests
    • 13.6.5. Culture Test
    • 13.6.6. Others
  • 13.7. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
  • 13.8. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by End-user
    • 13.8.1. Hospital
    • 13.8.2. Diagnostic Center
    • 13.8.3. Others
  • 13.9. Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis

14. Competition Landscape

  • 14.1. Meningitis Diagnostic Testing Market Share Analysis By Company, 2015
  • 14.2. Competition Matrix
  • 14.3. Company Profiles
    • 14.3.1. Fast Track Diagnostics Ltd. (FTD) - Siemens Healthineers
      • 14.3.1.1. Company Details
      • 14.3.1.2. Business Overview
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. Strategic Overview
      • 14.3.1.5. SWOT Analysis
    • 14.3.2. Thermo Fisher Scientific, Inc.
      • 14.3.2.1. Company Details
      • 14.3.2.2. Business Overview
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. Strategic Overview
      • 14.3.2.5. SWOT Analysis
    • 14.3.3. Abbott Laboratories.
      • 14.3.3.1. Company Details
      • 14.3.3.2. Business Overview
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. Strategic Overview
      • 14.3.3.5. SWOT Analysis
    • 14.3.4. Bio-Rad Laboratories, Inc.
      • 14.3.4.1. Company Details
      • 14.3.4.2. Business Overview
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. Strategic Overview
      • 14.3.4.5. SWOT Analysis
    • 14.3.5. Seegene Inc.
      • 14.3.5.1. Company Details
      • 14.3.5.2. Business Overview
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. Strategic Overview
      • 14.3.5.5. SWOT Analysis
    • 14.3.6. DiagCor Bioscience Inc. Ltd
      • 14.3.6.1. Company Details
      • 14.3.6.2. Business Overview
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. Strategic Overview
      • 14.3.6.5. SWOT Analysis
    • 14.3.7. BioFire Diagnostics (bioMerieux)
      • 14.3.7.1. Company Details
      • 14.3.7.2. Business Overview
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. Strategic Overview
      • 14.3.7.5. SWOT Analysis
    • 14.3.8. IMMY
      • 14.3.8.1. Company Details
      • 14.3.8.2. Business Overview
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. Strategic Overview
      • 14.3.8.5. SWOT Analysis
    • 14.3.9. Nanosphere (Luminex Corporation).
      • 14.3.9.1. Company Details
      • 14.3.9.2. Business Overview
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. Strategic Overview
      • 14.3.9.5. SWOT Analysis
Back to Top